Posted On: 11/29/2012 5:04:20 AM
Post# of 5789
Re: wowhappens28 #80
ARIA. ARIAD Announces Publication of Ponatinib Phase 1 Clinical Trial Results in the New England Journal of Medicine
Results demonstrate that ponatinib is highly active in heavily pretreated patients with CML and Ph + ALL
http://phx.corporate-ir.net/phoenix.zhtml?c=1...highlight=
chart.
http://stockcharts.com/h-sc/ui?s=ARIA&p=D...1015950122
(0)
(0)
